Company Quick10K Filing
Ocean Bio Chem
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-30
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-05-13 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-30
8-K 2020-08-26 Other Events
8-K 2020-08-10 Exhibits
8-K 2020-07-17 Earnings, Exhibits
8-K 2020-05-29
8-K 2020-05-26
8-K 2020-05-15
8-K 2020-04-27
8-K 2020-04-27
8-K 2020-03-19
8-K 2020-01-28
8-K 2019-11-14
8-K 2019-08-14
8-K 2019-06-03
8-K 2019-03-22
8-K 2018-11-14
8-K 2018-08-31
8-K 2018-08-14
8-K 2018-08-06
8-K 2018-05-18
8-K 2018-05-15
8-K 2018-04-26
8-K 2018-03-30
8-K 2018-03-19
8-K 2018-01-17

Ocean Bio Chem Financials

OBCI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Nexeo Solutions (NXEO) 757,054 11% 9.1 1% 2,179,100 1,359,600 4,040,400 451,900 19,100 169,200 1,533,454
Innophos Holdings (IPHS) 681,397 18% 20.0 2% 875,844 537,946 758,544 135,019 21,366 49,446 990,666
Hawkins (HWKN) 452,894 18% 9.4 7% 393,042 163,607 548,581 98,498 26,958 55,485 523,838
OMNOVA Solutions (OMN) 253,536 23% 10.7 1% 583,900 524,200 759,500 178,300 6,000 50,400 539,836
Foamix Pharmaceuticals (FOMX) 187,642 74% -2.8 -70% 81,583 28,054 1,168 860 -57,358 -57,278 159,797
MediWound (MDWD) 118,500 0% 35,276 0 0 0 0 118,411
Natural Alternatives International (NAII) 59,541 16% 4.0 4% 115,237 37,832 130,953 20,796 4,078 7,694 31,041
Mannatech (MTEX) 39,837 80% 1.4 2% 66,806 42,161 118,340 95,087 1,185 5,740 8,031
China Jo-Jo Drugstores (CJJD) 39,524 24% -45.8 -3% 87,150 65,526 111,004 26,449 -2,744 -481 22,025
Ocean Bio Chem (OBCI) 30,878 38% 8.3 7% 39,134 9,050 32,529 12,344 2,849 3,758 31,094
Cyanotech (CYAN) 18,636 41% 31.4 -3% 32,437 17,093 31,864 13,083 -1,090 788 24,748
CTI Industries (CTIB) 8,286 16% -2.5 -16% 32,897 30,950 33,481 5,342 -5,142 -3,674 9,028
Fuwei Films (FFHL) 6,793 14% 4.5 -2% 454,682 257,851 303,573 42,152 -8,960 -8,960 -40,115
Chromadex (CDXC) 249 55% 0.4 -54% 43,139 15,997 33,202 18,304 -23,294 -21,662 -8,507
HEXO (HEXO)
Aphria (APHA)
Canopy Growth Corporation (CGC)
Cronos Group (CRON)
Aurora Cannabis (ACB)
Happiness Biotech (HAPP) 0% 65,679 4,763 0 0 0 0 -14,801

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5398095856851,1287751,5085341,0066793,0722,8302,7141,8283,0632,0122,8479332,4682,4361,7961,0864,0703,3998683,4342,7475,0503,6884,3983,7342,7273,2873,986
Accounts Receivable3,5105,4872,5633,0512,9645,9122,9313,2063,8686,8814,4142,9684,2176,1544,8503,4824,0127,6075,0924,0905,5669,4144,9324,7796,2488,4544,9645,0039,07210,7925,6596,6938,55410,254
Inventory9,18410,6609,6289,9359,1459,5359,25710,0879,6908,5987,3688,7647,9508,7948,10910,0979,1059,3777,9159,0668,8008,9558,60110,16610,20910,1249,0749,96810,13411,65312,08612,52511,68311,408
PP&E5,2985,2155,2135,14113,40613,54113,86113,98014,18914,33614,37314,51714,81015,00915,09015,37115,77115,94616,09816,13716,21716,28616,47217,37618,96419,99321,71122,28722,63222,89123,07023,32923,45423,552
Assets20,20623,97419,87920,58120,27923,18821,01021,32121,79723,66822,24322,55922,76424,47623,98024,18524,22925,99723,98924,16324,31127,21025,67127,51727,27834,39931,99132,85735,49340,58335,23536,67037,18939,134
Accounts Payable1,0552,7121,1621,3211,5772,2751,4311,5561,5912,2661,0141,4911,3482,3971,4401,9961,4102,6181,1022,1191,7872,9941,5122,5472,2302,7761,8071,9292,5463,4091,4721,5871,4812,541
Long-Term Debt2,4982,4402,3402,2401,7371,9971,9021,8061,7091,6111,5131,4131,3131,2121,1101,007903798692585478369260149414,1654,0824,0203,9594,6224,5144,4194,3094,202
Liabilities7,59210,2125,8456,1715,1947,3244,5804,5604,5535,7093,9714,4513,9134,9493,9484,1774,1055,4213,3454,5774,0715,1453,1564,4993,8399,8227,0957,9979,49713,0247,8018,9748,4699,050
Stockholders' Equity12,30713,46513,75114,13914,82215,61016,17616,52817,02017,72718,04417,88618,63519,52820,03220,00820,12420,57620,64419,58620,24022,06522,51523,01723,43924,57724,89624,86125,99527,55927,43327,69628,72030,084
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8,2189,8846,8476,0057,88210,2624906,3128,17810,4417,7735,9218,81310,4328,7616,0028,73910,8378,4106,7508,72412,2075818,3929,90311,6525458,38411,39913,1829,08110,94512,503
Cost of Revenue5,2406,5384,9953,863101010101010101010101010107,274104,3685,0537,307105,2575,6247,5426,0135,4066,7458,6715,6606,4288,097
Gross Profit2,9783,3461,8522,1422,8653,2642,3562,2412,9723,1822,4932,0883,4313,5933,0182,0373,1643,5622,5772,3823,6714,9002,9213,1354,2784,1102,9742,9784,6544,5113,4214,5174,406
R&D1010
SG&A1,6741,2419721,0561,6041,3061,1611,1501,8791,5521,3481,1522,1321,6151,6411,4222,0572,3511,7502,4861,7941,9111,4691,5441,9842,0111,7591,5552,2892,1091,7002,2122,149
Tax22447976386446389140179923511941301684262328753144530346674248236617529125156364358209285319
Net Income3891,138217364363771464349173629318224411903511-1611429667-5416571,5284515049538542935231,1211,2727151,0101,125
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-3972,524-4101,758-1,4112,838-752784-2982,832-3717-4231,495-6051,246-1,6251,78513896-4973,289363-245522-1,498-180-6068651,329
Cash Investing-70-159-90-139-145-396-119-209-307-37-183-293-349-155-316-306-180-152-76-81-101-186-905-1,629-572-344-641-304-125-98
Cash Financing741-2,591600-1,1731,200-1,708-101-102278-403-40-543-103-104-105-110-112-111-91-653-113-121-117-664-664801,530-98-180-533